Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMC1P2 is a **pseudogene** that is homologous to the functional *PSMC1* gene, which encodes an ATPase subunit of the 26S proteasome complex involved in protein degradation. As a pseudogene, PSMC1P2 does not encode a functional protein, is not considered a therapeutic target, and is not known to have a biological role or disease association. It serves as a non-functional genomic remnant, and should not be confused with proteasome subunits that have therapeutic relevance[1][7]. - The presence of "pseudogene" in its name and confirmation from major gene databases indicate that **PSMC1P2 is not a protein-coding gene and does not function as a drug target**[1][7]. - If you are seeking information on proteasome ATPase subunits with therapeutic or biological relevance, refer to functional genes such as *PSMC1* or *PSMC2*, which are components of the 26S proteasome complex and have distinct enzymatic roles in proteostasis[5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome 26S subunit ATPase 1 pseudogene 2 (PSMC1P2).